CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria

Affiliation auteurs!!!! Error affiliation !!!!
TitreCD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria
Type de publicationJournal Article
Year of Publication2019
AuteursPaillassa J, Di Blasi R, Chevret S, Bernard S, Darmon M, Meignin V, Deau-Fischer B, Camus V, Casasnovas R-O, Cartron G, Chaoui D, Delwail V, Feugier P, Fornecker LMathieu, Gyan E, Haioun C, Kuhnowski F, Malfuson JValere, Marolleau J-P, Morel V, Damaj G, Quinquenel A, Rigaudeau S, Salanoubat C, Salmeron G, Sibon D, Azoulay E, Berquier M, Thieblemont C
JournalBLOOD
Volume134
Date PublishedNOV 13
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood-2019-129532